GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRF) » Definitions » Shiller PE Ratio

Starpharma Holdings (Starpharma Holdings) Shiller PE Ratio : (As of Jun. 07, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Starpharma Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Starpharma Holdings Shiller PE Ratio Historical Data

The historical data trend for Starpharma Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Shiller PE Ratio Chart

Starpharma Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Starpharma Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Starpharma Holdings's Shiller PE Ratio

For the Biotechnology subindustry, Starpharma Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Starpharma Holdings's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starpharma Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Starpharma Holdings's Shiller PE Ratio falls into.



Starpharma Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Starpharma Holdings's E10 for the fiscal year that ended in Jun23 is calculated as:

For example, Starpharma Holdings's adjusted earnings per share data for the fiscal year that ended in Jun23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun23 (Change)*Current CPI (Jun23)
=-0.027/124.1700*124.1700
=-0.027

Current CPI (Jun23) = 124.1700.

Starpharma Holdings Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.047 98.352 -0.059
201506 -0.046 99.838 -0.057
201606 -0.049 100.859 -0.060
201706 0.017 102.809 0.021
201806 -0.021 104.945 -0.025
201906 -0.028 106.617 -0.033
202006 -0.028 106.246 -0.033
202106 -0.038 110.332 -0.043
202206 -0.028 117.112 -0.030
202306 -0.027 124.170 -0.027

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Starpharma Holdings  (OTCPK:SPHRF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Starpharma Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Starpharma Holdings (Starpharma Holdings) Business Description

Traded in Other Exchanges
Address
4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings (Starpharma Holdings) Headlines